https://huver.ai/_next/static/chunks/journeyData-izZ-U5kG.js

1var e={en:[{date:`2024.09`,category:`FOUNDATION`,title:`Started with 20 healthcare professional interviews`,body:`Conducted structured field research to identify the clinical and operational problems worth solving.`},{date:`2025.01`,category:`AI INFRASTRUCTURE`,title:`AI Agent experimentation infrastructure secured`,body:`Secured technical instances through the Yonsei Graduate School of AI startup-support program and validated early agent architecture, orchestration, retrieval, and evaluation workflows.`},{date:`2025.02`,category:`HUVAGENT FOUNDATION`,title:`HUVAgent core engine and product development begins`,body:`Started building the orchestration engine that became the foundation of HUVAgent, including specialized-agent coordination and the first product experience.`},{date:`2025.03`,category:`TERTIARY-HOSPITAL RESEARCH`,title:`Joint research begins with a Korean tertiary hospital`,body:`Began Medical Multi-Agent AI research and developed a precision antibiotic-prescribing support sub-agent for a real clinical research setting.`},{date:`2025.05`,category:`KOREAN GOVERNMENT PROGRAM`,title:`Selected for the Preliminary Startup Package`,body:`Selected for the Preliminary Startup Package administered by Korea’s Ministry of SMEs and 

1Startups.`},{date:`2025.06`,category:`FOUNDATION`,title:`Selected for Yonsei Campus Town S-Cube`,body:`Established a dedicated research and product-development environment in the Yonsei University startup ecosystem.`},{date:`2025.06.30`,category:`KOREAN ENTITY`,title:`Korean entity incorporated`,body:`Established HUVER’s Korean entity and created the operating foundation for full-scale research, product, and business development.`},{date:`2025.07`,category:`PRODUCT`,title:`HUVA Chat development completed`,body:`Completed the first clinician-facing HUVA service and established a direct medical AI experience for healthcare professionals.`},{date:`2025.08`,category:`GLOBAL MARKET`,title:`Global healthcare market exploration`,body:`Joined the Global Startup Step-Up program to examine international healthcare workflows, market requirements, and expansion assumptions.`},{date:`2025.09`,category:`GLOBAL PROGRAMS`,title:`Selected for NVIDIA Inception, AWS Activate, and OpenAI Builder`,body:`Entered global technology programs supporting cloud infrastructure, model development, technical guidance, and market readiness.`},{date:`2025.10`,category:`RESEARCH`,title:`Medical Multi-Agent AI research accepted for oral presentation`,body:`A Hybrid Multi-Agent for Precision Antibiotic Prescribing was accepted for presentation at the Korean Society of Infectious Diseases conference.`},{date:`2025.11`,category:`PERFORMANCE`,title:`HUVAgent reaches #1 on HealthBench at approximately 70`,body:`Established the first top-ranked performance milestone and a baseline for subsequent model improvement.`},{date:`2025.12`,category:`PRODUCT`,title:`HUVA v1.0 and HUVAgent Deep Search developed`,body:`Completed the first clinical-deployment solution and advanced evidence retrieval through HUVAgent Deep Search.`},{date:`2026.01`,category:`U.S. COMPANY`,title:`Delaware C-Corp. incorporated`,body:`Established HUVER’s U.S. company as the legal foundation for its U.S.-led healthcare business and global expansion.`,status:`founded`},{date:`2026.01`,category:`U.S. PRODUCT`,title:`Development begins on a solution for U.S. hospital adoption`,body:`Started building around the workflows of U.S. clinics, ASCs, and urgent care, including payer operations and human-controlled execution.`},{date:`2026.02`,category:`U.S. FIELD RESEARCH`,title:`U.S. market study, hospital visits, and expert interviews`,body:`Visited healthcare sites and interviewed clinicians and healthcare professionals to understand local workflows, purchasing, and adoption requirements.`},{date:`2026.03–04`,category:`U.S. CLINIC PILOT`,title:`U.S. clinic adoption pilot and product feedback`,body:`Ran an adoption pilot with U.S. clinics, observed real clinical and administrative workflows, and incorporated direct user feedback into product refinement.`},{date:`2026.03`,category:`U.S. EXPANSION`,title:`Silicon Valley investor and clinical conversations advance`,body:`Received new investor review opportunities, discussed a clinical proof of concept with Stanford Medicine, and participated in NVIDIA GTC.`},{date:`2026.04`,category:`PROGRAM`,title:`Selected for KHIDI investment-attraction support`,body:`Connected with healthcare-focused investment institutions through the Korea Health Industry Development Institute program.`},{date:`2026.05`,category:`TEXAS MEDICAL CENTER`,title:`Became a Texas Medical Center Innovation Factory family company`,body:`Entered the Texas Medical Center ecosystem in Houston for clinical validation, partnerships, and U.S. commercialization.`},{date:`2026.06`,category:`PARTNERSHIP`,title:`Selected for NVIDIA NUP`,body:`Expanded access to NVIDIA’s technical ecosystem, expert support, and global AI network.`},{date:`2026.07`,category:`CORPORATE STRUCTURE`,title:`U.S. corporate flip completed`,body:`Completed HUVER’s corporate flip, establishing the Delaware C-Corp. as the parent company and the Korean entity as its subsidiary.`},{date:`2026.07`,category:`INTEGRATED PRODUCT`,title:`HUVA Work + Chat integrated v1.0 completed`,body:`Completed the first integrated platform connecting organization-wide workflows with clinician-facing medical intelligence.`},{date:`2026.08`,category:`U.S. CLINIC POC`,title:`In-clinic adoption PoCs underway with two U.S. clinics`,body:`Following remote product briefings and live demonstrations, both clinics expressed their intent to proceed with adoption. Implementation planning and in-clinic workflow deployment are now underway.`,status:`current`},{date:`2026.08`,category:`U.S. ECOSYSTEM`,title:`Selected for MARU SF Membership Cohort 5`,body:`Returned to the place where HUVER first shaped its U.S. expansion, now with a stronger product, a clearer plan, and relationships spanning a first Houston partner clinic and the TMC ecosystem.`,status:`current`},{date:`2026 H2`,category:`NEXT RELEASE`,title:`HUVA Work v2.0 planned`,body:`The next release is planned for the second half of 2026, expanding connected clinical and operational workflows.`,status:`planned`}],ko:[{date:`2024.09`,category:`시작`,title:`의료진 20인 고객 인터뷰`,body:`임상, 운영 현장에서 해결할 가치가 있는 문제를 정의하기 위해 체계적인 현장 리서치를 진행했습니다.`},{date:`2025.01`,category:`AI 인프라`,title:`AI Agent 실험 인프라 확보`,body:`연세대학교 인공지능대학원 스타트업 지원사업을 통해 기술 인스턴스를 확보하고 초기 Agent 구조, 오케스트레이션, 검색, 평가 워크플로우를 검증했습니다.`},{date:`2025.02`,category:`HUVAgent 기반`,title:`HUVAgent 기반 엔진, 제품 개발 시작`,body:`HUVAgent의 기반이 되는 오케스트레이션 엔진과 의료 특화 Agent 조율 구조를 개발하고 이를 초기 제품 경험으로 구현하기 시작했습니다.`},{date:`2025.03`,category:`상급종합병원 공동 연구`,title:`국내 상급종합병원 공동 연구 시작`,body:`국내 상급종합병원과 의료 Multi-Agent AI 공동 연구를 시작하고 실제 임상 연구 환경을 위한 항생제 정밀 처방 ë³´ì¡° sub-agent를 개발했습니다.`},{date:`2025.05`,category:`한국 정부지원사업`,title:`중소벤처기업부 예비창업패키지 선정`,body:`한국 중소벤처기업부 주관 예비창업패키지에 선정됐습니다.`},{date:`2025.06`,category:`기반`,title:`연세대학교 캠퍼스타운 S-Cube 입주 선정`,body:`연세대학교 창업 생태계 안에 전용 연구, 제품 개발 환경을 마련했습니다.`},{date:`2025.06.30`,category:`한국 법인`,title:`HUVER 한국 법인 설립`,body:`한국 법인을 설립하고 본격적인 연구개발, 제품 개발, 사업 확장을 위한 운영 기반을 구축했습니다.`},{date:`2025.07`,category:`제품`,title:`의료진 대상 HUVA Chat 개발 완료`,body:`의료진이 직접 사용할 수 있는 첫 HUVA 서비스를 완성하고 의료 AI 접근 경험의 기반을 마련했습니다.`},{date:`2025.08`,category:`글로벌 시장`,title:`글로벌 헬스케어 시장 탐색`,body:`글로벌 스타트업 Step-Up 프로그램을 통해 해외 의료 워크플로우, 시장 요구사항, 확장 가설을 검토했습니다.`},{date:`2025.09`,category:`글로벌 프로그램`,title:`NVIDIA Inception, AWS Activate, OpenAI Builder 선정`,body:`클라우드 인프라, 모델 개발, 기술 자문, 시장 진출을 지원하는 글로벌 기술 프로그램에 합류했습니다.`},{date:`2025.10`,category:`연구`,title:`의료 Multi-Agent 연구 대한감염학회 구연발표 채택`,body:`A Hybrid Multi-Agent for Precision Antibiotic Prescribing 연구가 대한감염학회 학술대회 구연발표로 채택됐습니다.`},{date:`2025.11`,category:`성능`,title:`HUVAgent, 약 70점으로 HealthBench 1위`,body:`첫 종합 1위 성과를 기록하고 이후 모델 성능 향상을 측정할 기준점을 세웠습ë

1‹ˆë‹¤.`},{date:`2025.12`,category:`제품`,title:`HUVA v1.0 및 HUVAgent Deep Search 개발`,body:`임상 현장 도입용 첫 솔루션을 완성하고 최신 근거 탐색 기능을 고도화했습니다.`},{date:`2026.01`,category:`미국 법인`,title:`Delaware C-Corp. 설립`,body:`미국 중심의 헬스케어 사업과 글로벌 확장을 위한 법적 기반으로 HUVER 미국 법인을 설립했습니다.`,status:`founded`},{date:`2026.01`,category:`미국 제품`,title:`미국 병원 도입용 솔루션 개발 착수`,body:`미국 클리닉, ASC, Urgent Care의 운영, 보험자 워크플로우, 의료진 통제를 기준으로 제품 개발을 시작했습니다.`},{date:`2026.02`,category:`미국 현지 조사`,title:`미국 시장 조사, 병원 방문, 전문가 인터뷰`,body:`미국 의료기관을 방문하고 의료진, 헬스케어 전문가를 인터뷰해 현지 업무, 구매, 도입 요건을 조사했습니다.`},{date:`2026.03–04`,category:`미국 클리닉 파일럿`,title:`미국 클리닉 도입 파일럿, 제품 피드백`,body:`미국 클리닉과 도입 파일럿을 진행하고 실제 임상, 행정 워크플로우를 관찰해 직접 받은 사용자 피드백을 제품 개선에 반영했습니다.`},{date:`2026.03`,category:`미국 진출`,title:`실리콘밸리 투자, 임상 논의 확대`,body:`투자 검토 기회와 Stanford Medicine 임상 PoC 논의를 확보하고 NVIDIA GTC에 참여했습니다.`},{date:`2026.04`,category:`프로그램`,title:`KHIDI 전문투자운용사 연계 지원사업 선정`,body:`한국보건산업진흥원 프로그램을 통해 헬스케어 전문 투자기관과의 연결 기반을 마련했습니다.`},{date:`2026.05`,category:`Texas Medical Center`,title:`TMC Innovation Factory family company 편입`,body:`Texas Medical Center 생태계에 진입해 임상 검증, 파트너십, 미국 사업화 기반을 확대했습니다.`},{date:`2026.06`,category:`파트너십`,title:`NVIDIA NUP 선정`,body:`NVIDIA 기술 생태계, 전문가 지원, 글로벌 AI 네트워크 연결을 확대했습니다.`},{date:`2026.07`,category:`법인 구조 전환`,title:`미국 법인 중심의 corporate flip 완료`,body:`Delaware C-Corp.를 모회사로 전환하고 한국 법인을 자회사로 두는 corporate flip을 완료했습니다.`},{date:`2026.07`,category:`통합 제품`,title:`HUVA Work, Chat 통합 v1.0 개발 완료`,body:`병원 전체 워크플로우와 의료진용 의료 인텔리전스를 연결하는 첫 통합 플랫폼을 완성했습니다.`},{date:`2026.08`,category:`미국 클리닉 PoC`,title:`미국 클리닉 2ê³³ 현장 도ìž

1… PoC 진행`,body:`비대면 제품 설명과 라이브 데모 시연을 거쳐 두 클리닉 모두 도입 진행 의향을 전달했습니다. 현재 실제 워크플로우 적용을 위한 실행 계획 수립과 현장 도입 PoC를 진행하고 있습니다.`,status:`current`},{date:`2026.08`,category:`미국 생태계`,title:`마루SF 멤버십 5기 선정`,body:`HUVER가 미국 진출 방향을 처음 구체화한 곳으로 더 나은 제품과 명확해진 계획을 가지고 돌아갑니다. 그곳에서 시작된 인연은 휴스턴의 첫 파트너 클리닉 및 TMC 생태계와의 연결로 이어졌습니다.`,status:`current`},{date:`2026 하반기`,category:`다음 제품`,title:`HUVA Work v2.0 예정`,body:`연결된 임상, 운영 워크플로우를 확장하는 다음 버전을 2026년 하반기에 선보일 예정입니다.`,status:`planned`}]};export{e as t};